{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:01:35Z","timestamp":1761764495634},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urology"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1016\/j.urology.2005.01.036","type":"journal-article","created":{"date-parts":[[2005,7,2]],"date-time":"2005-07-02T10:48:06Z","timestamp":1120301286000},"page":"82-87","source":"Crossref","is-referenced-by-count":71,"title":["Botulinum-A toxin for treatment of overactive bladder without detrusor overactivity: Urodynamic outcome and patient satisfaction"],"prefix":"10.1016","volume":"66","author":[{"given":"Heinrich","family":"Schulte-Baukloh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catarina","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Stolze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burkard","family":"St\u00fcrzebecher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helmut H.","family":"Knispel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2005.01.036_bib1","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0022-5347(17)42717-0","article-title":"Effects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients","volume":"139","author":"Dykstra","year":"1988","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.01.036_bib2","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1097\/01.ju.0000091281.50081.f0","article-title":"Botulinum A toxin urethral injection for the treatment of lower urinary tract dysfunction","volume":"170","author":"Kuo","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.01.036_bib3","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0022-5347(05)67283-7","article-title":"Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results","volume":"164","author":"Schurch","year":"2000","journal-title":"J Urol"},{"issue":"suppl 4","key":"10.1016\/j.urology.2005.01.036_bib4","first-page":"351","article-title":"Successful use of bladder botulinum toxin injection to treat refractory overactive bladder","volume":"169","author":"Chancellor","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.01.036_bib5","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1159\/000020314","article-title":"Perisphincteric injection of botulinum toxin type A","volume":"38","author":"Zermann","year":"2000","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2005.01.036_bib6","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1479-828X.2004.00163.x","article-title":"Pilot study of botulinum toxin type A in the treatment of chronic pelvic pain associated with spasm of the levator ani muscles","volume":"44","author":"Jarvis","year":"2004","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.urology.2005.01.036_bib7","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/01.ju.0000130652.27541.22","article-title":"Botulinum toxin type A","volume":"172","author":"Khera","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.01.036_bib8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","article-title":"The standardisation of terminology of lower urinary tract function","volume":"21","author":"Abrams","year":"2002","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2005.01.036_bib9","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00345-002-0301-4","article-title":"Prevalence and burden of overactive bladder in the United States","volume":"20","author":"Stewart","year":"2003","journal-title":"World J Urol"},{"issue":"suppl 11","key":"10.1016\/j.urology.2005.01.036_bib10","first-page":"565","article-title":"The prevalence of overactive bladder","volume":"6","author":"Milsom","year":"2000","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.urology.2005.01.036_bib11","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1464-410X.1981.tb03184.x","article-title":"A long-term study of the persistence of the urodynamic characteristics of the unstable bladder","volume":"53","author":"Booth","year":"1981","journal-title":"Br J Urol"},{"key":"10.1016\/j.urology.2005.01.036_bib12","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1464-410X.1989.tb05280.x","article-title":"Is the treatment of urgency incontinence a placebo response? Results of a five-year follow-up","volume":"64","author":"Aitchison","year":"1989","journal-title":"Br J Urol"},{"key":"10.1016\/j.urology.2005.01.036_bib13","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/BF02201987","article-title":"Efficacy and safety of two doses of tolterodine versus placebo in patients with detrusor overactivity and symptoms of frequency, urge incontinence, and urgency","volume":"15","author":"Jonas","year":"1997","journal-title":"World J Urol"},{"key":"10.1016\/j.urology.2005.01.036_bib14","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0022-5347(17)38459-8","article-title":"Randomized, double-blind, multicenter trial on treatment of frequency, urgency and incontinence related to detrusor hyperactivity","volume":"145","author":"Thuroff","year":"1991","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.01.036_bib15","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1464-410X.1980.tb03093.x","article-title":"The urodynamic and subjective results of treatment of detrusor instability with oxybutynin chloride","volume":"52","author":"Moisey","year":"1980","journal-title":"Br J Urol"},{"key":"10.1016\/j.urology.2005.01.036_bib16","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2165\/00002512-199506030-00007","article-title":"Oxybutynin","volume":"6","author":"Yarker","year":"1995","journal-title":"Drugs Aging"},{"key":"10.1016\/j.urology.2005.01.036_bib17","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/PL00007094","article-title":"Treatment of overactive bladder","volume":"19","author":"Appell","year":"2001","journal-title":"World J Urol"},{"key":"10.1016\/j.urology.2005.01.036_bib18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1464-410X.2004.04561.x","article-title":"Solifenacin appears effective and well tolerated in patients with symptomatic idiopathic detrusor overactivity in a placebo- and tolterodine-controlled phase 2 dose-finding study","volume":"93","author":"Chapple","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2005.01.036_bib19","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/nau.1930140206","article-title":"Short forms to assess life quality and symptom distress for urinary incontinence in women","volume":"14","author":"Uebersax","year":"1995","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2005.01.036_bib20","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/(SICI)1520-6777(1996)15:6<630::AID-NAU4>3.0.CO;2-G","article-title":"Development of a Symptom Severity Index and a Symptom Impact Index for stress incontinence in women","volume":"15","author":"Black","year":"1996","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2005.01.036_bib21","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0090-4295(99)00552-X","article-title":"Antibacterial mesh sling","volume":"55","author":"Choe","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.urology.2005.01.036_bib22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0302-2838(03)00136-2","article-title":"Botulinum-A toxin detrusor injection as a novel approach in the treatment of bladder spasticity in children with neurogenic bladder","volume":"44","author":"Schulte-Baukloh","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2005.01.036_bib23","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1464-410X.2003.04312.x","article-title":"Minimally invasive technique for outpatient local anaesthetic administration of intradetrusor botulinum toxin in intractable detrusor overactivity","volume":"92","author":"Harper","year":"2003","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2005.01.036_bib24","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.eururo.2003.12.004","article-title":"European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity","volume":"45","author":"Reitz","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2005.01.036_bib25","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.urology.2004.01.041","article-title":"Use of botulinum-A toxin for the treatment of refractory overactive bladder symptoms","volume":"63","author":"Rapp","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.urology.2005.01.036_bib26","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.urology.2003.12.007","article-title":"Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents","volume":"63","author":"Kuo","year":"2004","journal-title":"Urology"},{"issue":"suppl","key":"10.1016\/j.urology.2005.01.036_bib27","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0022-5347(18)37779-6","article-title":"A single surgeon\u2019s six-year experience with botulinum toxin into the bladder and urethra","volume":"171","author":"Chancellor","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.01.036_bib28","first-page":"608","article-title":"A possible explanation for the exceptional efficacy of botulinum toxin treatment for detrusor overactivity","volume":"23","author":"Apostolidis","year":"2004","journal-title":"Neurourol Urodyn"},{"issue":"suppl 3","key":"10.1016\/j.urology.2005.01.036_bib29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1569-9056(04)90513-1","article-title":"Botulinum toxin injections to treat overactive bladder","volume":"2","author":"Schmid","year":"2004","journal-title":"Eur Urol"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429505001081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429505001081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T23:42:48Z","timestamp":1586302968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429505001081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S0090429505001081"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2005.01.036","relation":{},"ISSN":["0090-4295"],"issn-type":[{"type":"print","value":"0090-4295"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}